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1. Introduction
  Liver is the most important organ, which plays a pivotal 
role in regulating various physiological processes in the 
body. It is involved in several vital functions, such as 
metabolism, secretion and storage. It has great capacity 
to detoxicate toxic substances and synthesize useful 
principles. Therefore, damage to the liver inflicted by 
hepatotoxic agents is of grave consequences[1]. Conventional 
or synthetic drugs used in the treatment of liver diseases 
are sometimes inadequate and can have serious adverse 
effects. On the other hand, Ayurveda, an indigenous system 
of medicine in India, has a long tradition of treating liver 
disorders with plant drugs[2]. 
  Sida cordata (Burn. F.) Borss. (syn: Sida vernicifolia 
Lam.), Family: malvaceae (S. cordata), commonly known as 
Bhumibala (Heartleaf fanpetal); is a procumbent, diffuse, 
much branched hairy herb with a very short main stem 
and long slender trailing branches that occasionally root 
at places of contact with the soil, found throughout India, 
mostly in dry places as weed on road sides; leaves long-
petioled, cordate to roundish with stellate hairs; flowers 
yellow, solitary or in pairs in the axils; fruits schizocarp 
located within the persistent calyx; seeds brownish, 
glabrous[3]. The species of Sida has been mentioned in 
Charak Samhita as brmhaniya-a bulk-promoting herb 
and as balya-tonic and prajasthapana-which promote 
reproduction[4]. The drug is useful in neurological disorders 
like hemiplegia, facial paralysis and sciatica, general 
debility, headache, opthalmia, dysuria, leucorrhoea, 
tuberculosis, diabetes, fever, rheumatism and uterine 
disorders[5,6]. To best of our knowledge there was lack of 
scientific reports available in support of traditional claim 
of its hepatoprotective potential. On the basis of leads 
available from folklore usage, a systematic research was 
undertaken to evaluate the possible effect of S. cordata 
Objective: To investigate the hepatoprotective potential of Sida cordata (Malvaceae) (S. cordata) 
in experimental rats to validate its traditional claim. Methods: Wister albino rats were divided 
into 6 groups: Group 栺 served as control; Group 栻 served as hepatotoxic (CCl4 treated) group; 
Group 栿, 桇 and 桋 served as (100, 200 and 400 mg/kg b.w.) S. cordata leaf extract (SCLE) treated 
groups; Group 桍 served as positive control (Silymarin) treated group. Liver marker enzymes 
serum glutamate oxyloacetic transaminase, serum glutamic pyruvic transaminase, pancreatic 
enzymatic antioxidants superoxide dismutase (SOD), lipid peroxidation, catalase (CAT), reduced 
glutathione (GSH) were measured and compared along with histopathological studies. Results: 
Obtained results show that the treatment with SCLE significantly (P<0.05-<0.001) and dose-
dependently reduced CCl4 induced elevated serum level of hepatic enzymes. Furthermore, 
SCLE significantly (up to P<0.001) reduced the lipid peroxidation in the liver tissue and restored 
activities of defence antioxidant enzymes GSH, SOD and CAT towards normal levels, which was 
confirmed by the histopathological studies. Conclusions: The results of this study strongly 
indicate the protective effect of SCLE against CCl4 induced acute liver toxicity in rats and thereby 
scientifically support its traditional use.
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leaf extract (SCLE) on the hepatotoxicity induced by CCl4 in 
experimental animals.
2. Materials and methods
2.1. Chemicals
  Silymarin (Microlabs, Mumbai), CCl4, Liquid paraffin 
(Qualigen’s, Mumbai), estimation of marker enzymes for liver 
functions such as SGOT, SGPT, ALP, total bilirubin, total 
protein were performed by using kits provided by Agappe 
Diagnostics Pvt. Ltd, Kerala, Semi-autoanalyser (MERCK 
Microlabs-300) was used as instrument for parameter testing. 
All other chemicals were purchased from SD fine chemicals, 
Mumbai and were of analytical grade.
2.2. Collection and preparation of plant extract
  S. cordata was collected from rural belt of Raipur district 
in Chhattisgarh, India in July 2010. The plant was identified 
and authenticated by Dr. MS Mondal, Additional Director, 
Central National Herbarium, Govt. of India, Howarh (India). 
The voucher (number is CNH/栺-304/2010/Tech.栻/360) 
was deposited in the institutional herbarium. The fresh 
leaves were washed under running tap water, air dried and 
powdered. Coarsely powdered sample (500 g) was defatted 
with petroleum ether (60-80 曟) and then extracted with 1 L
of 95% (v/v) ethanol and water mixture by hot percolation 
method. The extract was concentrated under vacuum to 
the solvent free residues (yield 17.06% w/w). Preliminary 
phytochemical analysis such as phenolic group, alkaloids, 
flavonoids, tannins, steroids and triterpenoids were 
calculated by the standard protocols[7].
2.3. Animals
  Healthy adult Wistar albino rats weighing (150-180 g) and 
Swiss albino mice (25-30 g) of either sex were procured from 
the animal house, Gayatri College of Pharmacy, Sambalpur 
(Reg. No. 1339/ac/10/CPCSEA). The animals were housed in 
spacious cages. The animals were maintained for 12 h in 
light and dark cycle at (28依2) 曟 in a well-ventilated animal 
house under natural conditions in large polypropylene 
cages and they were acclimatized to laboratory conditions 
for 10 days prior to the commencement of the experiment. 
The animals were fed with standard pelleted diet supplied 
by Anjali foods, Indore, India and provided with water ad 
libitum. All animal experiments were performed according to 
the ethical guidelines suggested by the Institutional animal 
ethics committee (IAEC, CPCSEA, India).
2.4. Acute oral toxicity studies
  Acute toxicity study was performed according to 
Organisation for Economic Co-operation and Development 
guideline No. 423[8]. Swiss albino mice (25-30 g) of either sex 
were divided into six groups with six animals in each group. 
SCLE was administered orally as a single dose to mice at 
different dose levels of 250, 500, 1 000, 1 500 and 2 000 mg/kg b.w.
Animals were observed periodically for the symptoms of 
toxicity and death within 24 h and then daily for 14 days.
2.5. Induction of hepatotoxicity and drug administration 
schedule
  Hepatoprotective activity was carried out using adult 
Wistar albino rats (150-180 g). The animals were grouped 
into 6 (six) groups of 6 (six) animals each group, maintained 
on standard diet and the food was withdrawn 18-24 h before 
the experiment though water was given ad libitum.
  Normal group 栺: Serve as normal control, 4% w/v gum 
acacia 1.0 mL/kg/b.w. orally for 5 days with 1.0 mL liquid 
paraffin given subcutaneously on 2nd and 3rd day; Positive 
control group 栻: Serve as toxicant receiving 4% w/v gum 
acacia 1.0 mL/kg/b.w. orally for 5 days with 1:1 v/v, CCl4 in 
liquid paraffin,1.0 mL/kg/b.w. subcutaneously on 2nd and 
3rd day; Test group 栿: Received SCLE in (1 %, w/v, CMC) at 
100 mg/kg/b.w. orally for 5 days with 1:1 v/v, CCl4 in liquid 
paraffin, 1.0 mL/kg/b.w. subcutaneously on 2nd and 3rd day; 
Test group 桇: Received SCLE in (1 %, w/v, CMC) at 200 mg/kg/b.w.
orally for 5 days with 1:1 v/v, CCl4 in liquid paraffin,
1.0 mL/kg/b.w. subcutaneously on 2nd and 3rd day; Test 
group 桋: Received SCLE in (1 %, w/v, CMC) at 400 mg/kg/b.w. 
orally for 5 days with 1:1 v/v, CCl4 in liquid paraffin, 1.0 mL/kg/b.w.
subcutaneously on 2nd and 3rd day; Test standard group 桍: 
Serve as standard receiving Silymarin 100 mg/kg/b.w. orally 
for 5 days with 1:1v/v, CCl4 in liquid paraffin, 1.0 mL/kg/b.w. 
subcutaneously on 2nd and 3rd day.
  Rats were anesthetized with anesthetic ether on 6th day 
and blood was collected from retro-orbital plexus and then 
sacrificed by cervical dislocation. The liver was carefully 
isolated and preserved in 10% formalin. The weight of each 
liver was recorded and then subjected to histopathological 
studies[9].
2.6. Estimation of biochemical parameters
  The collected blood was allowed to clot and serum was 
separated at 2 500 rpm for 15 min. The serum was collected 
and then diluted in the ratio of 1:10 with saline. Aliquot 
of the diluted serum was used for estimation of serum 
enzymes like serum glutamic pyruvic transaminase (SGPT), 
serum glutamate oxyloacetic transaminase (SGOT), alkaline 
phosphatase (ALP) and bilirubin. The enzyme levels 
were assayed using standard kits obtained from Agappe 
Diagnostics Pvt. Ltd, Kerala[10-13]. The liver homogenate 
was prepared and the clear supernatant was used for the 
estimation of lipid peroxidation (LPO)[14,15], total protein[16], 
reduced glutathione (GSH)[17,18] and antioxidant enzymes 
viz. catalase (CAT)[19] and superoxide dismutase (SOD) 
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levels[17,18].
2.7. Histopathological studies
  For histological studies, the liver tissues were fixed with 
10% phosphate buffered neutral formalin, dehydrated in 
graded (50%-100%) alcohol and embedded in paraffin. Thin 
sections (5M) were cut and stained with routine hematoxylin 
and eosin (H&E) stain for photo microscopic assessment. 
The initial examination was qualitative, with the purpose of 
determining histopathological lesions in liver tissue.
2.8. Statistical analysis
  The values were represented as mean依SEM. for six 
rats. Analysis of variance (ANOVA) test[20] was followed 
by individual comparison by Newman-Keuls test using 
Prism Pad software (Ver 3.0) for the determination of level 
of significance. The values of P<0.05 was considered 
statistically significant.
3. Results
3.1. Acute toxicity studies
  SCLE produces no mortality at 2 000 mg/kg. Therefore, 
one-tenth of the maximum no mortality dose of extract were 
selected as therapeutic middle dose (200 mg/kg) and just 
double as well as half dose of it as highest (400 mg/kg) and 
lowest dose (100 mg/kg) respectively, in this study.
3.2. Effect of SCLE on SGOT, SGPT, ALP and total bilirubin 
  The effect of various doses of SCLE were studied on serum 
marker enzymes and total bilirubin in CCl4 intoxicated 
animal. Hepatic injury induced by CCl4 caused significant 
changes in marker enzyme as SGOT by 275.10%, SGPT by 
397.88%, ALP by 128.29% and total bilirubin by 423.28% 
compared to control group. The percentage protection in 
marker enzyme of treated group at 100, 200 mg/kg as SGOT 
29.16 (P<0.01), 51.55 (P<0.001), SGPT 24.24 (P<0.05), 53.30 
(P<0.001), ALP 26.88 (P<0.01), 44.29 (P<0.001) and total 
bilirubin 27.27 (P<0.001), 50.85 (P<0.001) compared to CCl4 
group while maximum percentage protection in marker 
enzyme at the dose of 400 mg/kg and silymarin (100 mg/kg) as 
SGOT 67.52 (P<0.001), 70.62 (P<0.001), SGPT 74.32 (P<0.001), 
77.49 (P<0.001), ALP 53.79 (P<0.001), 54.63 (P<0.001) and total 
bilirubin 73.58 (P<0.001), 75.28 (P<0.001) which is almost 
comparable to the group treated with silymarin, a potent 
hepatoprotective drug used as reference standard (Table 1).
3.3. Estimation of LPO, GSH, SOD and CAT
  The results in Table 2 showed clear significant percentage 
change in the levels of LPO in CCl4 intoxicated rats as 
254.05 (P<0.001) compared to control group. Treatment 
with SCLE at the dose of 100, 200, 400 mg/kg significantly 
prevented this heave in levels and the percentage protection 
in LPO were 25.95 (P<0.05), 48.09 (P<0.01) and 63.36 
(P<0.001), respectively. The GSH, SOD and CAT content 
had significantly increased in SCLE treated groups whereas 
CCl4 intoxicated group had shown significantly decrease in 
these parameters compared to control group. The percentage 
Table 1
Effect of SCLE on SGOT (U/L), SGPT (U/L), ALP (U/L) and total bilirubin level (mg/dL) against CCl4 induced liver toxicity in rats.
Groups SGOT SGPT ALP TBL
Control 101.56依19.17  45.92依1011  68.66依59.23 0.73依0.53
CCl4  380.96依36.25
*  228.63依36.73* 156.75依37.71*  3.52依0.75*
SCLE 100   269.89依33.52##  173.21依52.27#  114.61依51.78##   2.56依0.23##
SCLE 200    184.59依23.72###    106.75依29.67###     87.33依23.14###    1.73依0.67###
SCLE 400    123.73依12.67###      58.72依42.87###     72.43依39.26###    0.93依0.43###
Silymarin    111.92依18.24###       51.46依11.21###     71.11依53.65###    0.87依0.22###
Values are mean依SEM. of 6 rats in each group. *P<0.001 compared with respective control group 栺; #P<0.05, ##P<0.01, ###P<0.001 
compared with group 栻 (CCl4). 
Table 2
Effect of SCLE on liver LPO (MDA nmole/min/mg of protein), GSH (nmole/mg of protein), SOD (unit/mg of protein) and CAT (unit/mg of protein) 
against CCl4 induced liver toxicity in rats. 
Groups LPO GSH SOD CAT
Control 0.37依0.23 0.92依0.11 26.67依3.54 57.67依6.82
CCl4 1.31依0.31
a 0.41依0.06a   8.89依2.72a 34.78依2.73a
SCLE 100 0.97依0.56a 0.57依0.15n 13.55依1.76 40.57依3.67
SCLE 200 0.68依0.43b 0.71依0.04b 18.11依2.34a 47.34依4.11a
SCLE 400 0.48依0.22c 0.82依0.23c 22.67依3.67c 54.41依2.45b
Silymarin 0.41依0.54c 0.88依0.05c 23.61依2.53c 55.44依1.43b
Values are mean依SEM. of 6 rats in each group. *P<0.001 compared with respective control group 栺; #P<0.05, ##P<0.01, ###P<0.001 
compared with group 栻 (CCl4).
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changed of GSH, SOD and CAT in CCl4 intoxicated group 
were as 55.43 (P<0.001), 66.67 (P<0.001) and 39.69 (P<0.001) 
respectively. The percentage protection in GSH as 39.02 
(ns), 73.17 (P<0.01), 100.00 (P<0.001) and SOD 52.42 (ns), 
103.71 (P<0.05), 155.00 (P<0.001) while in CAT 16.65 (ns), 
36.12 (P<0.05), 56.44 (P<0.01) at the dose levels 100, 200 and
400 mg/kg, respectively. In different doses level of SCLE,
400 mg/kg has shown maximum protections which were 
almost comparable to those of the normal control and 
silymarin.
3.4. Histopathological observations
  The histological observations (Figure 1) basically 
support the results obtained from serum enzyme assays. 
The histopathological examination of the liver control 
group showed normal hepatocytes with portal triad (A). 
The liver section of CCl4 treated rats showed typical 
centribular hepatocytic steatosis (both macrovesicular 
and microvesicular) and necrosis, limiting plate necrosis, 
apoptosis especially in the periportal hepatocytes and portal 
triaditis (B). This could be due to the formation of highly 
reactive free radicles because of oxidative stress caused by 
CCl4. Simultaneous administration of SCLE along with CCl4 
prevented these effects (C and D). The animals administered 
SCLE; 400 mg/kg showed a significant protection almost 
comparable to the control and silymarin treated groups (E 
and F).
Figure 1. Liver sections stained with haematoxylin and eosin.
(A) Control group; (B) CCl4 treated rats; (C) 100 mg/kg b.w. of SCLE 
treated rats; (D) 200 mg/kg b.w. of SCLE treated rats; (E) 400 mg/kg 
b.w. SCLE treated rats; (F) Silymarin treated rats(100 mg/kg b.w.).
4. Discussion
  Herbal medicines derived from plant extracts are being 
increasingly utilized to treat a wide variety of clinical 
disease. There is a growing interest in the pharmacological 
evaluation of various plants used in Indian traditional 
system of medicine[21]. In the present investigation, SCLE 
was evaluated for the hepatoprotective activity using CCl4 
induced hepatotoxicity in rat, the hepatotoxic effect of CCl4 
is due to the conversion by the cytochrome -p450 mixed 
function enzyme in the smooth endoplasmic reticulum 
of the liver and other organs to the highly reactive 
CCl3˙molecules[22]. Highly reactive CCl3˙ free radicals 
formation directly attacks the poly unsaturated fatty acids of 
the endoplasmic reticulum and thus causes over production 
of SGOT, SGPT, ALP, bilirubin and LDH enzymes[23-26]. 
The present study revealed a significant increase in the 
activities of SGOT, SGPT, ALP and serum bilirubin levels 
on exposure to CCl4, indicating considerable hepatocellular 
injury. Administration of SCLE at different doses level (100, 
200 and 400 mg/kg) attenuated the increased levels of the 
serum enzymes, produced by CCl4 and caused a subsequent 
recovery towards normalization comparable to the control 
groups animals. Reduction in the level of SGOT, SGPT 
and LDH towards the normal value is an indication of the 
hepatic cell regeneration process. Reduction in the level of 
ALP with the concurrent depletion with the raised bilirubin 
level suggests the stability of the biliary function. In CCl4 
intoxicated rats the level of total protein and albumin were 
significantly reduced, this might be due to the functional 
failure of the cytochrome -p450 complexes[27].The reduced 
activities of SOD and catalase observed and point out 
the hepatic damage in the rats administered with CCl4 
but the treated 100, 200 and 400 mg/kg of SCLE groups 
showed significant increase in the level of these enzymes, 
which indicates the antioxidant activity of the S. cordata. 
Furthermore, a decrease in hepatic tissue GSH level was 
observed in the CCl4 treated groups. The increase in hepatic 
GSH level in the rats treated with 100, 200 and 400 mg/kg 
of SCLE groups may be due de novo GSH synthesis or GSH 
regeneration. The level of lipid peroxide is a measure of 
membrane damage and alteration in structure and function 
of cellular membranes. In the present study, elevation 
of lipid peroxidation in the liver of rats treated with CCl4 
was observed. The increase in LPO levels in liver suggests 
enhanced lipid peroxidation leading to tissue damage and 
failure of antioxidant defense mechanism to prevent the 
formation of excessive free radicals[28]. Treatment with SCLE 
significantly reversed all the changes. Hence, it is possible 
that the mechanism of hepatoprotection of S. cordata may 
be due its antioxidant potential. The hepatoprotective 
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effect of the SCLE was further accomplished by the 
histopathological examinations. SCLE at different dose 
levels offers hepatoprotection, but 400 mg/kg is more 
effective and comparable with the standard drug silymarin 
(100 mg/kg). The histopathological examination of the liver 
sections confirmed that, normal liver cellular architecture 
was damage with CCl4 treated rats. However, the liver 
sections from SCLE treated rats showed that, the reduction 
in histopathological scores as well as cellular damage and 
thus further, confirming the hepatoprotective effect of SCLE. 
On preliminary qualitative phytochemical screening, SCLE 
revealed the presence of flavonoids, alkaloids, steroids, 
saponins, phenolic compounds, tannins and musilages 
are the major chemical constituents. These antioxidant 
phytochemicals might contribute to the hepatoprotective 
and antioxidant activities of SCLE. In conclusion, this 
study provide a lead to initiate detailed exploration of the 
untapped values of this plant as a traditional medicament 
offering protection against various liver aliments that were 
proven by biochemical and histopathological analysis. The 
SCLE has shown dose dependent activity among which at 
the dose level of 400 mg/kg, shows greater activity which is 
comparable with the control and standard groups. However, 
further investigations have been extended on the isolation 
and characterization of components that may be responsible 
for hepatoprotective activity, are in progress.
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